Abstract:OBJECTIVE:To describe the monitoring and control of pan-drug resistant Acinetobacter baumannii (XDRABA) colonization and infection in a medical intensive care unit (ICU), and to summarize the effective measures of surveillance of nosocomial infection and control.METHODS:Nonsurgical patients admitted to medical ICU of Peking University People's Hospital from September 2009 to April 2013 with length of ICU stay over 48 hours were surveyed. Number of cases of colonization and infection of XDRABA per month was recorded, and the clinical features of patients with XDRABA colonization and infection were observed. The control of XDRABA colonization and infection was divided into three stages: (1) Outbreak stage, from September 2009 to August 2010, the infection control measures included stringent hand hygiene and surface disinfection, use of disposable ventilator tubes and improvement in antibiotics use. (2) Environmental control stage, from September 2010 to April 2012, the infection control measures consisted of on-the-spot investigation, isolation of patients with XDRABA colonization and infection, tubes terminal environment disinfection. (3) Microbial screening stage, from May 2012 to April 2013, throat, nose and axillary swabs were obtained when the patients admitted.RESULTS:From 2009 September to 2013 April there was a total of 193 patients colonized or infected with XDRABA, and 64 patients died (mortality rate was 33.2%), and 133 (68.9%) patients were on mechanical ventilation. Patients with XDRABA colonization and infection had severer illness [acute physiology and chronic health evaluation II (APACHEII) score 20.3±6.7], longer ICU stay [(34.6±13.8) days]. In outbreak stage, number of cases with XDRABA colonization and infection was 5-9 per month. In environmental control stage, case number of XDRABA colonization and infection was 3-6 per month. In microbial screening stage, case number of XDRABA colonization and infection, which were already present, was 2-4 per month, and they were mainly admitted from emergency department (59.5%). The number of cases of ICU acquired XDRABA colonization and infection decreased from 2-3 to 0-1 per month.CONCLUSIONS:To control the colonization and infection of XDRABA, monitoring of microorganism, hand hygiene, isolation of patients with XDRABA colonization and infection, and stringent environment disinfection were very necessary.

Investigation and intervention in outbreak of lower respiratory tract infection caused by Acinetobacter baumannii

Drug resistance of Acinetobacter baumannii during 2009-2011

Homology Analysis and Nosocomial Infection Control on Outbreak of ICU Acinetobacter Baumannii Pneumonia

Risk Factors for and Clinical Outcomes of Polymicrobial Acinetobacter Baumannii Bloodstream Infections

Epidemiological study on hospital-acquired pneumonia of Acinetobacter baumannii

Risk Factors for Acquisition and Mortality of Multidrug-Resistant Acinetobacter Baumannii Bacteremia

Analysis of Drug Resistance of Acinetobacter Baumanii in Patients with Ventilator-Associated Pneumonia in Intensive Care Unit

Outbreak of Four Pan-drug resistant Acinetobacter baumanii Pulmonary Infections in Intensive Care Unit

Research on transmission risk exposure of pathogenic microorganisms in anesthesia procedures

Nosocomial Outbreak of Infection with Multidrug-ResistantAcinetobacter Baumanniiin a Medical Center in Taiwan

Drug resistance of Acinetobacter baumanniiin ICU and general wards: a comparative study

Monitoring and Control of Pan-Drug Resistant Acinetobacter Baumannii Colonization and Infection in a Medical Intensive Care Unit

Analysis of the transition of Acinetobacter sp' prevalence in low respiratory tract infection and their drug sensitivity

Prognosis and Risk Factor of Patients with Pneumonia Caused by Acinetobacter Baumannii in ICU

Survey on multi-resistant Acinetobacter baumannii infection and analysis of drug susceptibility

Research of Klebsiella Pneumoniae and Acinetobacter Baumannii Resistance Distribution Differences

Distribution of pathogenic bacteria and drug resistance of low respiratory tract infection during 2013 and 2016 in Beijing Jishuitan Hospital

Current status of epidemiology of carbapenems-resistant Acinetobacter baumannii infections and effectiveness of infection control

Nosocomial meningitis caused by Acinetobacter baumannii: risk factors and their impact on patient outcomes and treatments.

Risk factors for mortality of patients with pneumonia caused by Acinetobacter baumannii and Pseudomonas aeruginosa

Risk factors for poor prognosis of bloodstream infection caused by Acine-tobacter baumannii